Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 69 (4) , 826-839
Abstract
No abstract availableKeywords
Funding Information
- Research Grants Council, University Grants Committee (C7027-14 G, T12-710/16-R)
- Croucher Foundation
- National Natural Science Foundation of China (81672456)
This publication has 33 references indexed in Scilit:
- Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cellsCell Death & Disease, 2013
- Proteomic investigation of 5‐fluorouracil resistance in a human hepatocellular carcinoma cell lineJournal of Cellular Biochemistry, 2012
- AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathwaysHepatology, 2011
- Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosisAutophagy, 2011
- Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinomaInternational Journal of Cancer, 2011
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E MutationNew England Journal of Medicine, 2011
- Targeted Therapies for Hepatocellular CarcinomaGastroenterology, 2011
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Phase II Study of Sorafenib in Patients With Advanced Hepatocellular CarcinomaJournal of Clinical Oncology, 2006
- Protein Kinase C Delta Induces Apoptosis of Vascular Smooth Muscle Cells through Induction of the Tumor Suppressor p53 by Both p38-dependent and p38-independent MechanismsJournal of Biological Chemistry, 2005